Results 201 to 210 of about 76,436 (232)
Some of the next articles are maybe not open access.
Antimanic effects of verapamil
American Journal of Psychiatry, 1984When the authors compared the antimanic effects of verapamil, lithium carbonate, and placebo, no differences were seen between lithium and verapamil and both were more effective than placebo in reducing symptoms. No major side effects emerged during the study.
Price Wa +4 more
openaire +2 more sources
The Canadian Journal of Psychiatry, 1986
The authors report two cases of Bipolar Affective Disorder which were responsive to Lithium therapy in the past, but could no longer be treated with Lithium due to hyperparathyroidism in the first case and noncompliance in the second. In both cases, successful control of hypomania was achieved with Verapamil, but treatment of depression required the ...
Peter C. Williamson, Leigh Solomon
openaire +3 more sources
The authors report two cases of Bipolar Affective Disorder which were responsive to Lithium therapy in the past, but could no longer be treated with Lithium due to hyperparathyroidism in the first case and noncompliance in the second. In both cases, successful control of hypomania was achieved with Verapamil, but treatment of depression required the ...
Peter C. Williamson, Leigh Solomon
openaire +3 more sources
Postinfarct Treatment with Verapamil
Drugs, 1993In the Danish Verapamil Infarction Trial II (DAVIT II), treatment with verapamil 360 mg/day improved reinfarction-free survival compared with administration of placebo. Verapamil appears to effectively prevent reinfarction and sudden death, i.e. sudden events (hazard ratio 0.78 compared with placebo, 95% confidence limits 0.62 to 0.99).
openaire +3 more sources
Clinical Pharmacology and Therapeutics, 1981
To explore a possible interaction between digoxin and verapamil, a single-dose kinetic study of digoxin was performed and then repeated after 10 days of verapamil treatment in eight healthy subjects. Verapamil diminished the apparent central distribution volume of digoxin from 0.83 +/- 0.25 to 0.64 +2- 0.17 l/kg (P less than 0.05) and reduced total ...
Niels Anders Klitgaard +4 more
openaire +2 more sources
To explore a possible interaction between digoxin and verapamil, a single-dose kinetic study of digoxin was performed and then repeated after 10 days of verapamil treatment in eight healthy subjects. Verapamil diminished the apparent central distribution volume of digoxin from 0.83 +/- 0.25 to 0.64 +2- 0.17 l/kg (P less than 0.05) and reduced total ...
Niels Anders Klitgaard +4 more
openaire +2 more sources
Parkinsonism Unmasked by Verapamil
Clinical Neuropharmacology, 1993We report the case of a 55-year-old man who had a parkinsonian syndrome unresponsive to levodopa for 5 years and had been taking verapamil during the past 8 years. Parkinsonian signs improved markedly after withdrawal of verapamil, suggesting its role in unmasking the parkinsonism.
Esteban García-Albea +5 more
openaire +3 more sources
Verapamil Poisoning in an Infant
Pediatrics, 1984An 11-month-old female infant accidentally ingested 400 mg of verapamil. The patient developed coma, seizures, respiratory depression, bradycardia, and hypotension. Seizures have not previously been described in association with verapamil therapy or poisoning.
Frank H. Crespin, Donald Passal
openaire +3 more sources
Journal of Forensic Sciences, 1987
Abstract A case of fatal verapamil poisoning is reported. The pathologic and toxicologic findings are discussed.
John F. Koepke, Arthur J. McBay
openaire +3 more sources
Abstract A case of fatal verapamil poisoning is reported. The pathologic and toxicologic findings are discussed.
John F. Koepke, Arthur J. McBay
openaire +3 more sources
Drugs, 1977
Verapamil, a derivative of papaverine, originally developed as an antianginal drug is a highly effective antiarrhythmic drug against supraventricular tachyarrhythmias when administered intravenously. It is not a ~-adrenoceptor blocking agent (~-blocker) and differs from other antiarrhythmic agents in its mode of action.
openaire +3 more sources
Verapamil, a derivative of papaverine, originally developed as an antianginal drug is a highly effective antiarrhythmic drug against supraventricular tachyarrhythmias when administered intravenously. It is not a ~-adrenoceptor blocking agent (~-blocker) and differs from other antiarrhythmic agents in its mode of action.
openaire +3 more sources
Verapamil-induced Parkinsonism
The American Journal of Medicine, 1995Clara C. Faura +3 more
openaire +3 more sources